Results 281 to 290 of about 35,534 (303)

Targeting the “Undruggable” MYCN

Science Signaling, 2014
A drug that alters the conformation of the kinase Aurora A prevents its stabilizing interaction with the oncogenic transcription factor MYCN.
openaire   +1 more source

CT-based morphologic and radiomics features for the classification of MYCN gene amplification status in pediatric neuroblastoma

Child's Nervous System, 2022
E. Tan, Khurshid Z. Merchant, B. Kn, Arvind Cs, Joseph J. Zhao, S. Saffari, Poh Hwa Tan, Phua Hwee Tang   +7 more
semanticscholar   +1 more source

Circulating MYCN DNA Predicts MYCN-Amplification in Neuroblastoma

Journal of Clinical Oncology, 2005
Valérie, Combaret, Christophe, Bergeron, Rosa, Noguera, Isabelle, Iacono, Alain, Puisieux   +4 more
openaire   +2 more sources

Whole-tumour apparent diffusion coefficient (ADC) histogram analysis to identify MYCN-amplification in neuroblastomas: preliminary results

European Radiology, 2022
A. Ghosh, E. Yekeler, Deepali Dalal, Alexandria Holroyd, L. States   +4 more
semanticscholar   +1 more source

SMARCE1 promotes neuroblastoma tumorigenesis through assisting MYCN-mediated transcriptional activation

Oncogene, 2022
Xiaosong Hu, Ruochen Liu, Jianbing Hou, Wen Peng, Sicheng Wan, Minghao Xu, Yongsen Li, Guanghui Zhang, Xuan Zhai, Ping Liang, H. Cui   +10 more
semanticscholar   +1 more source

Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition

Cancer Discovery, 2013
Alexandre Puissant, Gabriela Alexe, Jun Qi   +2 more
exaly  

MYCN

2006
openaire   +1 more source

MYCN

2011
openaire   +1 more source

The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma

Cancer Cell, 2012
William Luther, Namrata Bhatnagar, yann Jamin   +2 more
exaly  

MYCN

2008
openaire   +1 more source